{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:03Z","timestamp":1790959323397,"version":"4.1.0"},"reference-count":67,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Nature Science Foundation of China","award":["81572753"],"award-info":[{"award-number":["81572753"]}]},{"name":"National Nature Science Foundation of China","award":["31660332"],"award-info":[{"award-number":["31660332"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer stem cells (CSCs) play a pivotal role in drug resistance and metastasis. Among the key players, Forkhead box O3a (FOXO3a) acts as a tumor suppressor. This study aimed to unravel the role of FOXO3a in mediating the inhibitory effect of metformin on cancer stemness derived from paclitaxel (PTX)-resistant non-small-cell lung cancer (NSCLC) cells. We showed that CSC-like features were acquired by the chronic induction of resistance to PTX, concurrently with inactivation of FOXO3a. In line with this, knockdown of FOXO3a in PTX-sensitive cells led to changes toward stemness, while overexpression of FOXO3a in PTX-resistant cells mitigated stemness in vitro and remarkably curbed the tumorigenesis of NSCLC\/PTX cells in vivo. Furthermore, metformin suppressed the self-renewal ability of PTX-resistant cells, reduced the expression of stemness-related markers (c-MYC, Oct4, Nanog and Notch), and upregulated FOXO3a, events concomitant with the activation of AMP-activated protein kinase (AMPK). All these changes were recapitulated by silencing FOXO3a in PTX-sensitive cells. Intriguingly, the introduction of the AMPK dominant negative mutant offset the inhibitory effect of metformin on the stemness of PTX-resistant cells. In addition, FOXO3a levels were elevated by the treatment of PTX-resistant cells with MK2206 (an Akt inhibitor) and U0126 (a MEK inhibitor). Collectively, our findings indicate that metformin exerts its effect on FOXO3a through the activation of AMPK and the inhibition of protein kinase B (Akt) and MAPK\/extracellular signal-regulated kinase (MEK), culminating in the suppression of stemness in paclitaxel-resistant NSCLC cells.<\/jats:p>","DOI":"10.3390\/ijms242316611","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:47:43Z","timestamp":1700642863000},"page":"16611","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a"],"prefix":"10.3390","volume":"24","author":[{"given":"Zhimin","family":"Tang","sequence":"first","affiliation":[{"name":"Jiangxi Provincial Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medical Sciences, Nanchang University, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nanchang Joint Program, Queen Mary School, Nanchang University, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Yu","sequence":"additional","affiliation":[{"name":"Nanchang Joint Program, Queen Mary School, Nanchang University, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-5289","authenticated-orcid":false,"given":"Zhijun","family":"Luo","sequence":"additional","affiliation":[{"name":"Jiangxi Provincial Key Laboratory of Tumor Pathogens and Molecular Pathology, Department of Pathophysiology, School of Basic Medical Sciences, Nanchang University, Nanchang 330031, China"},{"name":"Nanchang Joint Program, Queen Mary School, Nanchang University, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(00)02074-2","article-title":"The taxanes: An update","volume":"355","author":"Crown","year":"2000","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"110S","DOI":"10.1002\/j.1875-9114.1997.tb03813.x","article-title":"Clinical overview of the taxanes","volume":"17","author":"Goldspiel","year":"1997","journal-title":"Pharmacotherapy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/83.24.1797-a","article-title":"Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer","volume":"83","author":"Holmes","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_5","first-page":"3620","article-title":"Mechanisms of Taxol-induced cell death are concentration dependent","volume":"58","author":"Torres","year":"1998","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrm2190","article-title":"Stressing the role of FoxO proteins in lifespan and disease","volume":"8","author":"Burgering","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1111\/febs.16221","article-title":"FOXOs: Masters of the equilibrium","volume":"289","author":"Gui","year":"2022","journal-title":"FEBS J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1119(02)01100-9","article-title":"Cloning and analysis of a FoxO transcription factor from Xiphophorus","volume":"302","author":"Rudd","year":"2003","journal-title":"Gene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1073\/pnas.0405454101","article-title":"Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins","volume":"101","author":"Aoki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/sj.emboj.7600476","article-title":"FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK","volume":"23","author":"Essers","year":"2004","journal-title":"EMBO J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: A nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(04)00298-3","article-title":"Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation","volume":"117","author":"Seoane","year":"2004","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/cdd.2009.36","article-title":"p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription","volume":"16","author":"Chiacchiera","year":"2009","journal-title":"Cell Death Differ."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1073\/pnas.0810956106","article-title":"The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations","volume":"106","author":"Dubrovska","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/stem.696","article-title":"FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity","volume":"29","author":"Sunayama","year":"2011","journal-title":"Stem Cells"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E2526","DOI":"10.1073\/pnas.1522612113","article-title":"NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance","volume":"113","author":"Chiu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41418-019-0389-3","article-title":"Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/0008-5472.CAN-13-3451","article-title":"Small-Molecule ONC201\/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt\/Foxo3a\/TRAIL-Dependent Manner","volume":"75","author":"Prabhu","year":"2015","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/dmd.107.015495","article-title":"Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine","volume":"35","author":"Zhou","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6230162","DOI":"10.1155\/2019\/6230162","article-title":"Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis","volume":"2019","author":"Yao","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40880-017-0184-9","article-title":"Metformin targets multiple signaling pathways in cancer","volume":"36","author":"Lei","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/cc.9.6.10994","article-title":"Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena","volume":"9","author":"Menendez","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tips.2012.11.005","article-title":"Metformin and cancer: From the old medicine cabinet to pharmacological pitfalls and prospects","volume":"34","author":"Fisel","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10495-015-1158-5","article-title":"Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells","volume":"20","author":"Soo","year":"2015","journal-title":"Apoptosis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pharep.2017.11.007","article-title":"Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines","volume":"70","author":"Tessarollo","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/abbs\/gmx106","article-title":"Metformin as an anti-cancer agent: Actions and mechanisms targeting cancer stem cells","volume":"50","author":"Saini","year":"2018","journal-title":"Acta Biochim. Biophys Sin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-015-0203-8","article-title":"NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin","volume":"8","author":"Suwei","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.18632\/oncotarget.2657","article-title":"Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4\/ALK and LKB1 status","volume":"5","author":"Xiao","year":"2014","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1038\/srep05810","article-title":"Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation","volume":"4","author":"Hu","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Paterson, C., Kilmister, E.J., Brasch, H.D., Bockett, N., Patel, J., Paterson, E., Purdie, G., Galvin, S., Davis, P.F., and Itinteang, T. (2021). Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma. Life, 11.","DOI":"10.3390\/life11101106"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/MCB.21.10.3534-3546.2001","article-title":"Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX","volume":"21","author":"Brownawell","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2005.08.004","article-title":"FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction","volume":"2","author":"Kitamura","year":"2005","journal-title":"Cell Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1074\/jbc.M901758200","article-title":"MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation","volume":"284","author":"Fu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_36","first-page":"4212","article-title":"MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway","volume":"24","author":"Cui","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncb1676","article-title":"ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation","volume":"10","author":"Yang","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1158\/0008-5472.CAN-14-0135","article-title":"AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis","volume":"74","author":"Chou","year":"2014","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41467-023-38430-8","article-title":"Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK\/MDM2\/p53 axis","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56395","DOI":"10.18632\/oncotarget.10892","article-title":"Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin","volume":"7","author":"Zechner","year":"2016","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.15252\/embj.201695534","article-title":"AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction","volume":"36","author":"Pan","year":"2017","journal-title":"EMBO J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3892\/mmr.2014.2012","article-title":"FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4\u2032-di-n-octyl genistein","volume":"9","author":"Ning","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Garofalo, C., Capristo, M., Manara, M.C., Mancarella, C., Landuzzi, L., Belfiore, A., Lollini, P.L., Picci, P., and Scotlandi, K. (2013). Metformin as an adjuvant drug against pediatric sarcomas: Hypoxia limits therapeutic effects of the drug. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0083832"},{"key":"ref_44","first-page":"1765","article-title":"Metformin suppresses sonic hedgehog expression in pancreatic cancer cells","volume":"34","author":"Nakamura","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kwan, H.T., Chan, D.W., Cai, P.C., Mak, C.S., Yung, M.M., Leung, T.H., Wong, O.G., Cheung, A.N., and Ngan, H.Y. (2013). AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt\/beta-catenin signaling activity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053597"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1940-6207.CAPR-12-0053","article-title":"Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt\/beta-catenin signaling","volume":"5","author":"Subramaniam","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_47","first-page":"3807","article-title":"Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status","volume":"9","author":"Cufi","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3892\/ol.2016.4323","article-title":"The impact of metformin and salinomycin on transforming growth factor beta-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines","volume":"11","author":"Koeck","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1073\/pnas.1409844111","article-title":"Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells","volume":"111","author":"Janzer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lonardo, E., Cioffi, M., Sancho, P., Sanchez-Ripoll, Y., Trabulo, S.M., Dorado, J., Balic, A., Hidalgo, M., and Heeschen, C. (2013). Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076518"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.2337\/db08-1512","article-title":"Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin","volume":"58","author":"Li","year":"2009","journal-title":"Diabetes"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Canto","year":"2009","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20090613","article-title":"AMPKalpha1 regulates the antioxidant status of vascular endothelial cells","volume":"421","author":"Colombo","year":"2009","journal-title":"Biochem. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"104852","DOI":"10.1016\/j.tiv.2020.104852","article-title":"Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK\/FOXO3a signaling pathway","volume":"66","author":"Potocnjak","year":"2020","journal-title":"Toxicol. Vitr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41389-018-0078-y","article-title":"MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells","volume":"7","author":"Lin","year":"2018","journal-title":"Oncogenesis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41389-022-00392-9","article-title":"TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a","volume":"11","author":"Liu","year":"2022","journal-title":"Oncogenesis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.celrep.2016.07.038","article-title":"NOTCH1 Inhibits Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5\/Tip60 Complex","volume":"16","author":"Adamowicz","year":"2016","journal-title":"Cell Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e002772","DOI":"10.1136\/jitc-2021-002772","article-title":"Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3","volume":"9","author":"Chung","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fonc.2014.00040","article-title":"In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies","volume":"4","author":"McDermott","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3748\/wjg.v13.i2.250","article-title":"Antiproliferation and apoptosis induction of paeonol in HepG2 cells","volume":"13","author":"Xu","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2010.12.004","article-title":"PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo","volume":"654","author":"Jin","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/1087057114521867","article-title":"A New Bliss Independence Model to Analyze Drug Combination Data","volume":"19","author":"Zhao","year":"2014","journal-title":"J. Biomol. Screen."},{"key":"ref_64","first-page":"3866","article-title":"Metformin reverses stem cell-like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial-mesenchymal transformation","volume":"18","author":"Feng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1073\/pnas.1914786117","article-title":"Transcriptional suppression of AMPKalpha1 promotes breast cancer metastasis upon oncogene activation","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Chen, Q., Jin, J., Guo, W., Tang, Z., Luo, Y., Ying, Y., Lin, H., and Luo, Z. (2022). PEBP4 Directs the Malignant Behavior of Hepatocellular Carcinoma Cells via Regulating mTORC1 and mTORC2. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158798"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jcp.25054","article-title":"Cell-penetrating and endoplasmic reticulum-locating TAT-IL-24-KDEL fusion protein induces tumor apoptosis","volume":"231","author":"Zhang","year":"2016","journal-title":"J. Cell Physiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/23\/16611\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:27:09Z","timestamp":1760131629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/23\/16611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":67,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["ijms242316611"],"URL":"https:\/\/doi.org\/10.3390\/ijms242316611","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}